Benzinga | Oct 25, 2021 04:08PM EDT

Trxade Health Q3 EPS $(0.16) Misses $(0.13) Estimate, Sales $2.60M Beat $1.99M Estimate

Trxade Health (NASDAQ:MEDS) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 900 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $2.60 million which beat the analyst consensus estimate of $1.99 million by 30.65 percent. This is a 58.94 percent decrease over sales of $6.33 million the same period last year.